Ann Janssens

Myeloablative Conditioning Predisposes Patients for<i>Toxoplasma gondii</i>Reactivation after Allogeneic Stem Cell Transplantation

Stef Meers, Katrien Lagrou, Koen Theunissen et al. · Clinical Infectious Diseases · 2010 · 81 citations · Full text

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia

Ann Janssens, Francesco Rodeghiero, David R. Anderson et al. · Annals of Hematology · 2016 · 50 citations · Full text

Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study

Katja De Paepe, Charlotte Bevernage, Frederik De Keyzer et al. · Cancer Imaging · 2013 · 41 citations · Full text

A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice

Michael Steurer, Philippe Quittet, Helen Α. Papadaki et al. · European Journal Of Haematology · 2016 · 41 citations

HA14-1 potentiates apoptosis in B-cell cancer cells sensitive to a peptide disrupting IP3 receptor / Bcl-2 complexes

Haidar Akl, Rita Maria Laura La Rovere, Ann Janssens et al. · The International Journal of Developmental Biology · 2015 · 21 citations

Chemoprevention Strategy, Apoptosis, Immunology +17